The Pharmaceuticals Division is the bedrock of Zoiko Healthcare’s clinical and commercial strategy delivering an expansive portfolio of therapeutics that are highly scalable, clinically proven, and economically accessible. We design and deliver solutions that address the escalating global burden of non-communicable diseases (NCDs) and infectious diseases, while advancing a patient-first model built on integrity, safety, and innovation.
Covers widely prescribed treatments across hypertension, diabetes, respiratory illness, infectious disease, and chronic pain engineered for cost-efficiency, stability, and bulk-scale deployment.
Includes oncology injectables, adjuvant chemotherapies, dual-action antiplatelets, and advanced antimicrobial agents for hospital grade care and critical interventions.
Fixed-dose combinations tailored to improve long-term adherence in cardiometabolic and geriatric patients adapted for use in low-resource and mobile populations.
All medicines are manufactured under WHO-GMP, cGMP, and ISO 9001-certified environments, with stability testing protocols aligned to Zone IVa and IVb markets. Our regulatory footprint spans the United States, United Kingdom, select EU states, Sub-Saharan Africa, the Caribbean, and Southeast Asia — reflecting a global compliance and dossier readiness strategy.
Beyond commercial reach, Zoiko Pharmaceuticals is also grounded in its commitment to sustainable access with fair pricing models, pooled procurement programs, and collaborative research tied to WHO’s Model List of Essential Medicines and the United Nations Sustainable Development Goals (SDGs). From molecule to market, we are building a globally integrated, therapeutically diverse, and socially responsible pharmaceutical platform engineered to save lives at scale.
Cytotoxics, adjuvants, hormonal and targeted oral agents
AMR-conscious antibiotics, antivirals, and combination antiparasitics
antihypertensives, anticoagulants, statins
oral hypoglycemics, combination therapies
non-opioid analgesics and neuropathic treatments
beta-agonists, corticosteroids, nebulization kits
We welcome partnerships across the value chain — from research and clinical trials to distribution, licensing, and investment. We invite you to connect at:
